StonvexLoading…
StonvexStonvexStonvexCore line items from RHLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $407.80M | $462.06M | $344.35M | $223.48M |
Operating Income | $-5.80M | $143.26M | $107.71M | $66.25M |
Net Income | $61.50M | $-5.92M | $-4.21M | $-3.98M |
EPS (Diluted) | $7.19 | $-0.69 | $-0.49 | $-0.47 |
Total Assets | $6.21B | $333.40M | $293.17M | $253.29M |
Total Liabilities | $3.13B | $255.70M | $251.59M | $249.15M |
Cash & Equivalents | $113.10M | $161.40M | $98.25M | $99.86M |
Free Cash Flow OCF − CapEx | $-124.20M | $189.23M | $123.93M | $65.31M |
Shares Outstanding | 8.26M | 8.50M | 8.53M | 8.53M |